Postpartum thyroiditis differential diagnosis: Difference between revisions
Sunny Kumar (talk | contribs) |
Usama Talib (talk | contribs) No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto | [[Postpartum thyroiditis]] must be differentiated from other causes of [[thyroiditis]], such as [[De Quervain's thyroiditis]], [[Hashimoto's thyroiditis]], [[Riedel's thyroiditis]], and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause [[hypothyroidism]]. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing [[thyrotoxicosis]] must also be considered in the differential diagnosis. | ||
==Differentiating Postpartum Thyroiditis from other Diseases== | ==Differentiating Postpartum Thyroiditis from other Diseases== | ||
Line 15: | Line 15: | ||
! style="background:#4479BA; color: #FFFFFF;" | Conditions | ! style="background:#4479BA; color: #FFFFFF;" | Conditions | ||
! style="background:#4479BA; color: #FFFFFF;" |Causes | ! style="background:#4479BA; color: #FFFFFF;" |Causes | ||
! style="background:#4479BA; color: #FFFFFF;" |Age | ! style="background:#4479BA; color: #FFFFFF;" |Age of onset (years) | ||
! style="background:#4479BA; color: #FFFFFF;" |Pathological findings | ! style="background:#4479BA; color: #FFFFFF;" |Pathological findings | ||
! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach | ! style="background:#4479BA; color: #FFFFFF;" |Diagnostic approach | ||
Line 22: | Line 22: | ||
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*All ages, peak at 30-50 | *All ages, peak at 30-50 | ||
Line 28: | Line 28: | ||
*Lymphocytic infiltration | *Lymphocytic infiltration | ||
*Germinal centers | *Germinal centers | ||
*Fibrosis (in some variants) | *[[Fibrosis]] (in some variants) | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 41: | Line 41: | ||
*20-60 | *20-60 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Giant cells | *[[Giant cells]] | ||
*Granulomas | *[[Granulomas]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] ( | * [[Thyroid function tests|Decreased TSH]] ([[thyrotoxicosis]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] absent or very low titer | *[[Thyroid peroxidase|TPO antibodies]] absent or very low titer | ||
*[[I-123 thyroid imaging|I-123]] uptake decreased | *[[I-123 thyroid imaging|I-123]] uptake decreased | ||
Line 51: | Line 51: | ||
| align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Silent thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*All ages, peak at 30-40 | *All ages, peak at 30-40 | ||
Line 58: | Line 58: | ||
*Lymphoid follicles | *Lymphoid follicles | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism) | * [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 65: | Line 65: | ||
| align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Postpartum thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Autoimmune | *[[Autoimmune]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Childbearing age | *Childbearing age | ||
Line 71: | Line 71: | ||
*Lymphocytic infiltration | *Lymphocytic infiltration | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Increased TSH]] (hypothyroidism) and/or | *[[Thyroid function tests|Increased TSH]] ([[hypothyroidism]]) and/or | ||
* [[Thyroid function tests|Decreased TSH]] (transient hypothyroidism) | * [[Thyroid function tests|Decreased TSH]] (transient [[hypothyroidism]]) | ||
*[[Thyroid peroxidase|TPO antibodies]] present in high titer | *[[Thyroid peroxidase|TPO antibodies]] present in high titer | ||
*[[I-123 thyroid imaging|I-123]] uptake usually decreased | *[[I-123 thyroid imaging|I-123]] uptake usually decreased | ||
Line 82: | Line 82: | ||
*30-60 | *30-60 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Dense fibrosis | *Dense [[fibrosis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Normal TSH]] (euthyroidism) | *[[Thyroid function tests|Normal TSH]] (euthyroidism) | ||
Line 90: | Line 90: | ||
| align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]] | | align="center" style="background:#DCDCDC;" |[[Suppurative thyroiditis]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Infection | *[[Infection]] | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Children, 20-40 | *Children, 20-40 | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*Abscess formation | *[[Abscess]] formation | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
*[[Thyroid function tests|Normal TSH]] (euthyroidism) | *[[Thyroid function tests|Normal TSH]] (euthyroidism) | ||
Line 120: | Line 120: | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]] | | rowspan="3" style="background:#DCDCDC;" |[[Primary hypothyroidism]] | ||
| align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] ([[Hashimoto's thyroiditis]]) | | align="center" style="background:#DCDCDC;" |[[Hashimoto's thyroiditis|Autoimmune]] | ||
([[Hashimoto's thyroiditis]]) | |||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | - | ||
Line 146: | Line 147: | ||
*[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass. | *[[Riedel's thyroiditis]] usually presents with hard and fixed thyroid mass. | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" | | | align="center" style="background:#DCDCDC;" |Infectious thyroiditis | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | | align="center" style="padding: 5px 5px; background: #F5F5F5;" | + | ||
Line 219: | Line 220: | ||
| align="center" style="background:#DCDCDC;" |Trauma induced | | align="center" style="background:#DCDCDC;" |Trauma induced | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Radioiodine induced | | align="center" style="background:#DCDCDC;" |[[Radioiodine]] induced | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Thyroidectomy | | align="center" style="background:#DCDCDC;" |[[Thyroidectomy]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism | | align="center" style="background:#DCDCDC;" |Subclinical hypothyroidism | ||
Line 237: | Line 238: | ||
|- | |- | ||
|} | |} | ||
<br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism| | <br style="clear:left" />''(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; [[Thyroid peroxidase]] antibodies. (*)[[TSH]] may be decreased transiently in the [[thyrotoxicosis]]. (**)TPOAb may be present in drug-induced [[Hypothyroidism|hypothyroidism]] or [[hyperthyroidism]] such as [[Interferon-alpha]], [[Interleukin 2|interleukin-2]], and [[lithium]].'' | ||
===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis=== | ===Differentiating postpartum thyroiditis from other causes of thyrotoxicosis=== | ||
*Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ |format= |work= |accessdate=}}</ref> | *Postpartum thyroiditis can initially present with [[thyrotoxicosis]] which must be differentiated from other causes of [[thyrotoxicosis]].<ref name="pmid16734054">{{cite journal |vauthors=Bindra A, Braunstein GD |title=Thyroiditis |journal=Am Fam Physician |volume=73 |issue=10 |pages=1769–76 |year=2006 |pmid=16734054 |doi= |url=}}</ref><ref name="pmid19949140">{{cite journal |vauthors=McDermott MT |title=In the clinic. Hypothyroidism |journal=Ann. Intern. Med. |volume=151 |issue=11 |pages=ITC61 |year=2009 |pmid=19949140 |doi=10.7326/0003-4819-151-11-200912010-01006 |url=}}</ref><ref name="urlThyroiditis — NEJM">{{cite web |url=http://www.nejm.org/doi/full/10.1056/NEJMra021194 |title=Thyroiditis — NEJM |format= |work= |accessdate=}}</ref><ref name="pmid18177256">{{cite journal |vauthors=Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR |title=Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002) |journal=Thyroid |volume=17 |issue=12 |pages=1211–23 |year=2007 |pmid=18177256 |doi=10.1089/thy.2006.0235 |url=}}</ref><ref name="pmid18415684">{{cite journal |vauthors=Lania A, Persani L, Beck-Peccoz P |title=Central hypothyroidism |journal=Pituitary |volume=11 |issue=2 |pages=181–6 |year=2008 |pmid=18415684 |doi=10.1007/s11102-008-0122-6 |url=}}</ref><ref name="pmid25905413">{{cite journal |vauthors=De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J |title=Clinical Strategies in the Testing of Thyroid Function |journal= |volume= |issue= |pages= |year= |pmid=25905413 |doi= |url=}}</ref><ref name="urlClinical Finding and Thyroid Function in Women with Struma Ovarii">{{cite web |url=https://www.hindawi.com/archive/2013/717584/ |title=Clinical Finding and Thyroid Function in Women with Struma Ovarii |format= |work= |accessdate=}}</ref><ref name="pmid25146390">{{cite journal |vauthors=Vaidya B, Pearce SH |title=Diagnosis and management of thyrotoxicosis |journal=BMJ |volume=349 |issue= |pages=g5128 |year=2014 |pmid=25146390 |doi= |url=}}</ref><ref name="urlThink thyrotoxicosis factitia - measure thyroglobulin | The BMJ">{{cite web |url=http://www.bmj.com/content/349/bmj.g5128/rr/763450 |title=Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ |format= |work= |accessdate=}}</ref> | ||
{| class="wikitable" align="center" style="border: 0px; margin: 3px;" | {| class="wikitable" align="center" style="border: 0px; margin: 3px;" | ||
! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease | ! colspan="2" rowspan="2" align="center" style="background: #4479BA; color: #FFFFFF; " |Disease | ||
Line 250: | Line 251: | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Pain | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Free T4 | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Free T4 | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3 | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3 | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>† | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> T3RU<small>† | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> Thyroglobin | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small>Thyroglobin | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TRH | ||
! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody | ! align="center" style="background: #4479BA; color: #FFFFFF; " |<small> TSH Receptor Antibody | ||
Line 328: | Line 329: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
* | * Opthalmopathy and [[dermopathy]] may be present | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | | align="center" style="background:#DCDCDC;" |[[Toxic thyroid nodule]] | ||
Line 357: | Line 358: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Inappropriately normal or increased TSH | *Inappropriately normal or increased [[TSH]] | ||
|- | |- | ||
| rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | | rowspan="1" style="background:#DCDCDC;" |[[Tertiary hyperthyroidism]] | ||
Line 372: | Line 373: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Inappropriately normal or increased TSH | *Inappropriately normal or increased [[TSH]] | ||
|- | |- | ||
| rowspan="2" style="background:#DCDCDC;" |Drug induced | | rowspan="2" style="background:#DCDCDC;" |Drug induced | ||
Line 387: | Line 388: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*High urinary iodine | *High urinary [[iodine]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]] | | align="center" style="background:#DCDCDC;" |[[Amiodarone|Amiodarone type 2]] | ||
Line 401: | Line 402: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*High urinary iodine | *High urinary [[iodine]] | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" |Others | | rowspan="3" style="background:#DCDCDC;" |Others | ||
Line 416: | Line 417: | ||
| align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | | align="center" style="padding: 5px 5px; background: #F5F5F5;" |Absent | ||
| align="left" style="padding: 5px 5px; background: #F5F5F5;" | | | align="left" style="padding: 5px 5px; background: #F5F5F5;" | | ||
*Decreased thyroglobulin | *Decreased [[thyroglobulin]] | ||
|- | |- | ||
| align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] | | align="center" style="background:#DCDCDC;" |[[Trophoblastic disease]] |
Revision as of 19:11, 30 October 2017
Postpartum thyroiditis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Postpartum thyroiditis differential diagnosis On the Web |
American Roentgen Ray Society Images of Postpartum thyroiditis differential diagnosis |
Risk calculators and risk factors for Postpartum thyroiditis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]
Overview
Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis. Postpartum thyroiditis must also be differentiated from other diseases which cause hypothyroidism. As postpartum thyroiditis may cause transient thyrotoxic symptoms, the diseases causing thyrotoxicosis must also be considered in the differential diagnosis.
Differentiating Postpartum Thyroiditis from other Diseases
Differentiating postpartum thyroiditis from other causes of thyroiditis
- Postpartum thyroiditis must be differentiated from other causes of thyroiditis, such as De Quervain's thyroiditis, Hashimoto's thyroiditis, Riedel's thyroiditis, and suppurative thyroiditis.[1][2][3]
Conditions | Causes | Age of onset (years) | Pathological findings | Diagnostic approach |
---|---|---|---|---|
Hashimoto's thyroiditis |
|
|
| |
Painful subacute (De Quervain's) thyroiditis |
|
|
| |
Silent thyroiditis |
|
|
| |
Postpartum thyroiditis |
|
|
| |
Riedel's thyroiditis |
|
|
|
|
Suppurative thyroiditis |
|
|
|
Differentiating postpartum thyroiditis from other causes of hypothyroidism
- Postpartum thyroiditis must be differentiated from other causes of hypothyroidism on the basis of history and symptoms and laboratory findings:[4][5][1][6][7][8]
Disease | History and symptoms | Laboratory findings | Additional findings | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TPOAb^ | |||
Primary hypothyroidism | Autoimmune | - | - | ↑* | ↓ | Normal/↓ | Normal/↓ | Normal/↑ | Normal | Present (high titer) |
|
Riedel's thyroiditis | - | - | Normal/↑ | Normal/↓ | Normal/↓ | Normal/↓ | Normal | Normal | Usually present |
| |
Infectious thyroiditis | + | + | Normal | Normal | Normal | Normal | Normal | Normal | Absent |
| |
Transient hypothyroidism | Subacute (de Quervain's) thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Low/absent |
|
Postpartum thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal/↑ | Present (high titer) |
| |
Silent thyroiditis | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Present (high titer) |
| |
Others | Drug-induced | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | Normal/↑ | Normal | Absent** |
|
Radiation-induced | |||||||||||
Trauma induced | |||||||||||
Radioiodine induced | |||||||||||
Thyroidectomy | |||||||||||
Subclinical hypothyroidism | - | - | ↑ | Normal | Normal | Normal | Normal | Normal | Normal/↑ |
|
(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies. (*)TSH may be decreased transiently in the thyrotoxicosis. (**)TPOAb may be present in drug-induced hypothyroidism or hyperthyroidism such as Interferon-alpha, interleukin-2, and lithium.
Differentiating postpartum thyroiditis from other causes of thyrotoxicosis
- Postpartum thyroiditis can initially present with thyrotoxicosis which must be differentiated from other causes of thyrotoxicosis.[4][5][1][6][7][8][9][10][11]
Disease | History and symptoms | Laboratory findings | Additional findings | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Pain | TSH | Free T4 | T3 | T3RU† | Thyroglobin | TRH | TSH Receptor Antibody | TPOAb^ | |||
Thyroiditis | Postpartum thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal/↑ | Absent | Present (high titer) |
|
Hashimoto's thyroiditis (Hashitoxicosis) | - | - | ↑* | ↓ | Normal/↓ | Normal/↓ | Normal/↑ | Normal | Absent | Present (high titer) |
| |
Subacute (de Quervain's) thyroiditis | +/- | +/- | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Absent | Low/absent |
| |
Silent thyroiditis | - | - | ↑/↓ | ↓/↑ | Normal | ↓ | ↑ | Normal | Absent | Present (high titer) |
| |
Primary hyperthyroidism | Grave's disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | ↑ | Normal | Present | Absent |
|
Toxic thyroid nodule | - | - | ↓ | ↑ | Normal/↑ | ↑(hot nodule) | Normal/↑ | Normal | Absent | Absent |
- | |
Secondary hyperthyroidism | Pituitary adenoma | - | - | ↑ | ↑ | Normal/↑ | ↑ | Normal/↑ | Normal | Absent | Absent |
|
Tertiary hyperthyroidism | Tertiary hyperthyroidism | - | - | ↑ | ↑ | ↑ | ↑ | Normal/↑ | ↑ | Absent | Absent |
|
Drug induced | Amiodarone type 1 | - | - | ↓ | ↑ | Normal/↑ | ↓ | Normal/↑ | Normal | Absent | Absent |
|
Amiodarone type 2 | - | - | ↓ | ↑ | Normal/↑ | Absent/↓ | Normal/↑ | Normal | Absent | Absent |
| |
Others | Factitious thyrotoxicosis | - | - | ↓ | ↑ | Normal/↑ | ↓ | ↓ | Normal | Absent | Absent |
|
Trophoblastic disease | - | - | ↓ | ↑ | Normal/↑ | ↑ | - | Normal | Absent | Absent |
- | |
Struma ovarii | - | - | ↓ | ↑ | Normal/↑ | ↓ | - | Normal | Absent | Absent |
- |
(†)T3RU; Triiodothyronine Resin uptake. (^)TPOAb; Thyroid peroxidase antibodies.
Stages | Peek
presenting purpural month |
Disease | Symptoms and Signs | Labs | Mechanisum | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Fatiuge | Neck
swelling |
Low
mood |
Irritability | TSH | FT4 | TPO ab | ESR | RAI
U |
Thyroid U/S | Microscopic
Picture | ||||
Persistent
hyperthyroidism |
4-6 | Grave's disease | + | Small
painful mass |
Present | Present
early |
Low | High | Absent | ↑ | ↑ | diffusely
enlarged hypervascular heterogeneous echotexture |
hyperplastic follicles due to eosinophilic cytoplasm scalloping |
TSHR
activating antibodies |
Transient
hyperthyroidism |
2-4 | Silent thyroiditis | + | Small
painless goiter |
Present
late |
Present
early |
Normal
or Low |
High | 50% | NL | ↓ | markedly
decreased vascularity variable heterogeneous texture |
Lymphocytic
infiltration Lymphoid follicles |
CD4
T-cell activation mutation |
Postpartum thyroiditis | + | Small
painless goiter |
Present
late |
Present
early |
Normal
or Low |
High | >80% | ↑ | ↓ | hypoechoic
diffusely enlarged with normal or decreased vasclarity |
variable
heterogeneous texture hypoechogenic |
Reg
T-cell gain in function mutation | ||
Subacute (de Quervain's) | + | Small
painful mass |
Present
late |
Present
early |
Normal
or Low |
High | Absent | ↑ | ↓ | diffusely
enlarged & normal or decreased vasclarity |
Giant cells
Granulomas |
systemic
viral infections | ||
Factitious | + | Normal | Absent | Present
early |
Normal
or Low |
High | Absent | NL | ↓ | Normal | Normal
histology |
thyroixine
intake | ||
acute suppurative
thyroiditis |
+ | Small
painful mass |
Present
late |
Present
early |
Normal
or Low |
High | Absent | ↑ | ↓ | variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
polymorphonuclear leukocytes
lymphocytes exudates |
infections
viral,bacterial | ||
Destructive
hyperthyroidism |
4-6 | Subacute (de Quervain's) | + | Small
painful mass |
Present
late |
Present
early |
Normal
or Low |
High | Absent | ↑ | ↓ | diffusely
enlarged &normal or decreased vasclarity |
Giant cells
Granulomas |
systemic
viral infections |
Postpartum | + | Small
painless goiter |
Present
late |
Present
early |
Normal
or Low |
High | >80% | ↑ | ↓ | hypoechoic
diffusely enlarged& normal or decreased vasclarity |
variable
heterogeneous texture hypoechogenic |
Reg
T-cell gain in function mutation | ||
acute suppurative
thyroiditis |
+ | Small
painful mass |
Present
late |
Present
early |
Normal
or Low |
High | Absent | ↑ | ↓ | variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
polymorphonuclear leukocytes
lymphocytes exudates |
infections
viral,bacterial | ||
Transient
hypothyroidism |
2-4 | Postpartum | + | Small
painless goiter |
Present
late |
Present
early |
Normal
or High |
Low | >80% | ↑ | ↓ | hypoechoic
diffusely enlarged & normal or decreased vasclarity |
variable
heterogeneous texture , hypoechogenic |
Reg
T-cell gain in function mutation |
Silent | + | Small
painless goiter |
Present
late |
Present
early |
Normal
or High |
Low | Present | NL | ↓ | markedly
decreased vascularity variable heterogeneous texture |
Lymphocytic infiltration
Lymphoid follicles |
CD4
T-cell activation mutation | ||
Subacute (de Quervain's) | + | Small
painful mass |
Present
late |
Present
early |
Normal
or High |
Low | Absent | ↑ | ↓ | diffusely
enlarged normal or decreased vasclarity |
Giant cells
Granulomas |
systemic
viral infections | ||
acute suppurative | + | Small
painful mass |
Present
late |
Present
early |
Normal
or High |
Low | Absent | ↑ | ↓ | variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
polymorphonuclear leukocytes
lymphocytes exudates |
infections
viral,bacterial | ||
Persistent
hypothyroidism |
6 | Riedel's | + | Small
painful mass |
Present
late |
Present
early |
High | Low | 75% | ↑ | ↓ | homogeneously
hypoechoic fibrotic invasion of the adjacent structures |
lymphocytes, plasma cells, and eosinophils in a dense matrix of hyalinized connective tissue | infections
viral,bacterial |
Postpartum | + | Small
painless goiter |
Present
late |
Present
early |
High | Low | >80% | ↑ | ↓ | hypoechoic
diffusely enlarged& normal or decreased vasclarity |
variable
heterogeneous texture, hypoechogenic |
Reg
T-cell gain in function mutation | ||
Hashimoto's | + | Painful
mass |
Present
late |
Present
early |
High | Low | 95% | ↑ | ↓ | heterogeneous
echotexture decreased vasclarity hypoechoic micronodules |
lymphoid
follicles Germinal centers Hurthle cells |
Reg T-cell
dysfunction | ||
Acute suppurative
thyroiditis |
+ | Small
painful mass |
Present
late |
Present
early |
High | Low | Absent | ↑ | ↓ | variable
heterogeneous texture perithyroidal hypoechoic space due to abcess |
polymorphonuclear leukocytes
lymphocytes exudates |
systemic
viral infections |
References
- ↑ 1.0 1.1 1.2 "Thyroiditis — NEJM".
- ↑ Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
- ↑ Akuzawa N, Yokota T, Suzuki T, Kurabayashi M (2017). "Acute suppurative thyroiditis caused by Streptococcus agalactiae infection: a case report". Clin Case Rep. 5 (8): 1238–1242. doi:10.1002/ccr3.1048. PMC 5538065. PMID 28781832.
- ↑ 4.0 4.1 Bindra A, Braunstein GD (2006). "Thyroiditis". Am Fam Physician. 73 (10): 1769–76. PMID 16734054.
- ↑ 5.0 5.1 McDermott MT (2009). "In the clinic. Hypothyroidism". Ann. Intern. Med. 151 (11): ITC61. doi:10.7326/0003-4819-151-11-200912010-01006. PMID 19949140.
- ↑ 6.0 6.1 Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR (2007). "Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002)". Thyroid. 17 (12): 1211–23. doi:10.1089/thy.2006.0235. PMID 18177256.
- ↑ 7.0 7.1 Lania A, Persani L, Beck-Peccoz P (2008). "Central hypothyroidism". Pituitary. 11 (2): 181–6. doi:10.1007/s11102-008-0122-6. PMID 18415684.
- ↑ 8.0 8.1 De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Stockigt J. "Clinical Strategies in the Testing of Thyroid Function". PMID 25905413.
- ↑ "Clinical Finding and Thyroid Function in Women with Struma Ovarii".
- ↑ Vaidya B, Pearce SH (2014). "Diagnosis and management of thyrotoxicosis". BMJ. 349: g5128. PMID 25146390.
- ↑ "Think thyrotoxicosis factitia - measure thyroglobulin | The BMJ".